Australian situation update: diphtheria outbreak (AUS-2026) - 28 Aug 2026

The series has covered this outbreak since May and last carried it in the 26 July post. In the month since, a new national guideline was issued, the national count passed 500, and a severe respiratory case reached a child in the Perth metropolitan area, source unknown.

This post catches the thread up. It opens with the disease itself, then carries the Perth case, the outbreak from October 2025 to this week, the century of records behind it, the government response and the dispute over its speed, and the instrument the winter produced. Where figures come from different bodies on different dates, both are given with their dates.

Sources are at the end.

.

[Diphtheria - the disease, its treatment, and the vaccine most adults do not know they have had]

• What diphtheria is. A life-threatening, highly contagious bacterial infection, largely eradicated in Australia by the 1940s. Essentially all human diphtheria, including this outbreak, is caused by one bacterium: toxin-producing Corynebacterium diphtheriae.
  • (A rarer cousin, C. ulcerans, causes occasional cases through animal contact and unpasteurised milk; it is not part of this outbreak.)
• One bacterium, two diseases. The same organism causes two different illnesses depending on where it takes hold:
  • in the throat, respiratory diphtheria, the dangerous form;
  • on the skin, cutaneous diphtheria, sores and ulcers that do not heal (the Kimberley materials' recognition cue: deep sores, often on the legs), far less dangerous to the person carrying it but contagious.
    • Contact with a person with skin lesions nearly quintuples the odds of infection, the most consistent finding in the global risk-factor evidence, and a skin case can seed the throat form in the next person.
  • This outbreak is about two-thirds skin form, one-third throat form.
• The throat form.
  • It starts like a cold: sore throat, fever, swollen neck glands, weakness.
  • Within two to three days, dead tissue forms a thick grey membrane over the nose, tonsils and throat that makes it hard to breathe and swallow, and most deaths come from asphyxia as it obstructs the airway, within one to two weeks of onset.
  • The toxin the bacteria release into the bloodstream then reaches the heart in 10 to 25 per cent of patients (toxic cardiomyopathy, seven to fourteen days in, commonly fatal, with no effective treatment once established) and the nerves in up to a quarter of untreated cases, weeks to months later.
• The odds of dying. SA Health gives the case fatality rate for respiratory diphtheria as 5 to 10 per cent, a treated-setting figure; the CDC's evidence summary records reported ratios of 29 per cent, up to 50 per cent in resource-limited settings.
  • The difference between those numbers is access to antitoxin and healthcare.
• How it spreads. From coughing and sneezing, from skin contact with an infected sore, and from contaminated items such as shared bedding, towels and clothing.
  • Both forms transmit, and people with no symptoms can carry and pass on the bacterium.
• The timing of it. Symptoms begin two to five days after exposure; chains run on an average eight-day interval between cases; and each case seeds two to three more in a susceptible population, a basic reproduction number of 1.7 to 4.3.
• How common it is. Globally, far from gone: 22,625 cases reported in 2019, the most since 1996, with the century's largest outbreak infecting 8,640 people in the Rohingya refugee camps from 2017; recent outbreaks track under-vaccination, conflict and displacement.
  • In Australia, before this outbreak: 46 notifications in the 21 years to 2019, and no respiratory diphtheria in an Australian child for two decades.

The treatment

• The antitoxin. The most effective treatment for the throat form is diphtheria antitoxin alongside antibiotics. It neutralises toxin in the blood but not toxin already bound to tissue, so speed decides outcomes: the risk of death roughly doubles with each day of delay, from 4.2 per cent given within 48 hours to 24 per cent by day five.
  • It carries an anaphylaxis risk requiring acute-care administration, and scarcity runs from the global to the particular: worldwide stockpiles hold enough for 500 to 2,500 cases with no WHO-prequalified product on the market.
  • The guideline notes public health units may need to assist with access, three of the NT's 34 respiratory cases actually received it (first for want of supply, then under a pseudomembrane-only rule).
  • Confirmatory Elek toxin testing (the classical plate assay that proves a strain is producing toxin, not merely carrying the gene) is not available in Australia at all; isolates go overseas.
• The antibiotics. Antibiotics cut carriage from an average of 18.5 days to 5.2, and go to cases and contacts alike. The caveat the evidence summary itself flags: the WHO's recommended first-line macrolides rest on a single trial of 86 patients.

The vaccine

• What it is, and what it is called.
  • The diphtheria vaccine is a toxoid: a deactivated copy of the toxin that teaches the body to neutralise the real one.
  • It has been on the Australian schedule since 1932 and is never given on its own: since 1953 it has come combined with tetanus and whooping cough vaccine in one injection, originally as the "triple antigen," today as the childhood DTP doses and the adult booster dTpa (Boostrix is the common brand).
  • Most adults know it only as "the whooping cough shot."
  • The combination is deliberate outbreak policy too: the national guideline recommends pertussis-containing formulations for outbreak response, for opportunistic protection against other diseases.
• Who gets it, and when.
  • Childhood doses at two, four, six and eighteen months and four years, with an adolescent dose at eleven to thirteen.
  • For adults, a booster at fifty (recommended but not funded under the National Immunisation Program), or every five years from fifty for those at higher risk.
  • A dose is also recommended in each pregnancy, between 20 and 32 weeks, given as part of the pertussis vaccination: every baby comes with a diphtheria booster for its mother.
  • Victorian clinical guidance states the full ladder as one rule: every ten years for all adults, every five for people living in or travelling to higher-risk areas.
• What it does. A full primary course is 87 per cent effective against symptomatic respiratory disease, rising to 99 per cent with five doses; among people who get sick anyway, it is 81 per cent effective against severe disease and 93 per cent against death.
  • The protection shows in this outbreak's own numbers: hospitalisation among respiratory cases was 42.8 per cent for those with two or fewer recorded doses, against 15.2 per cent for those with three or more.
• What it does not do.
  • It does not stop you catching or carrying the bacterium.
  • It cuts transmission by an estimated 60 per cent, largely by keeping infections mild and quiet: among fully vaccinated people who become infected, 90 per cent become symptomless carriers.
  • Hence 87.3 per cent of this outbreak's respiratory cases being fully vaccinated, the mostly mild course through a high-coverage population, and the guideline's statement of the vaccine's job as preventing severe disease rather than infection.
  • A vaccinated outbreak looks exactly like this.
• The decay signal. Protection wanes. Among fully vaccinated cases, the median time since the last dose was 7.1 years for respiratory cases against 3.6 for cutaneous: the severe form is concentrating in the people whose boosters are oldest.
• What that means in practice. An adult who had a pertussis booster in the last ten years, commonly around the arrival of a grandchild, may have had a diphtheria booster without knowing it. An adult whose last "whooping cough shot" is more than ten years old is out of date for diphtheria, and has no signal telling them so.
• The mirror. Somalia's outbreak ran on the opposite structure: 87 per cent of cases there had no vaccination history, cohorts born under low coverage. Australia's runs at the same number, inverted: the same share of respiratory cases fully vaccinated, and the harder shape to fix with vaccine alone.

.

[The first metro case - a child in Perth, and a source that has not been identified]

This section concerns a child. No identifying detail is carried beyond what the department has published. The school is identified only as the department identified it.

• The case. A child in the Perth metropolitan area has severe respiratory diphtheria. Investigations are continuing to determine where the infection was acquired. The WA Department of Health announced the case this week alongside a push for vaccination.
• The school response.
  • Contact tracing is under way, with public health support to a school in the north-eastern suburbs.
  • Under the new national guideline, a high-risk school contact is anyone with direct interaction with the case for two full school days or twenty cumulative hours in a week, and gets the full suite regardless of vaccination status: a week's symptom monitoring, swabs, antibiotics regardless of the test result, and a booster if more than twelve months from the last dose.
  • Contacts stay at school but avoid the vulnerable until 72 hours of antibiotics or a negative swab; only the case is excluded.
• The department's assessment, and its ask.
  • Risk to the broader community is low, because diphtheria spreads through close or prolonged contact.
  • Dr Paul Armstrong, Director of Communicable Disease Control, said vaccine remained the most effective protection against severe illness caused by diphtheria: "We particularly want to increase vaccination among adolescents and adults, and I strongly encourage anyone eligible to take up the offer."
• The state around it. The case arrives against 224 cases notified across regional WA; the state's own weekly report has 226 statewide, the difference being exactly its two metropolitan cases.
• A first, with a caveat. The West's headline calls this the first respiratory case in the Perth metropolitan area. Two metro cases have been on the books since June; their form is stated nowhere. The headline requires both to have been cutaneous, which nothing in the record confirms or denies.

The structural finding. The department's two statements sit against each other and both are accurate: the risk to the broader community is low, and the source has not been identified, which means the chain that produced it has not been closed. A case with an unknown source in a capital city is a different fact from a case in a known outbreak zone, because the tracing back to a source has nowhere to start.

.

[The outbreak - October 2025 to this week]

• The origin, as far as anyone knows.
  • NT Chief Health Officer Paul Burgess traces the strain to an importation "into northern Queensland in about 2022," a 25-case burst that "just seemed to disappear"; the peer-reviewed genomics tell it differently, the NT genomes forming their own clade that split from Queensland's around 2017, siblings rather than parent and child, in a tree holding Solomon Islands and Papua New Guinea sequences.
  • On the ground: first cutaneous case May 2025, first respiratory cases March 2026. Burgess's August account has the disease "first creeping into the capital city, Darwin, before gradually spreading throughout its rural pockets and the northernmost section of Western Australia," where his May account had it beginning in remote communities; both framings are his, unreconciled.
  • How it began, and why it spread almost exclusively among Indigenous Australians, "isn't understood yet."
• The dates. The CDC dates notifications rising from October 2025, a marked increase from February 2026, and the national peak between mid-April and early June; the NT peaked in May, WA in June. The series' May record had recognition in December 2025.
• The vaccination position underneath it. Burgess: remote-community childhood vaccination rates, once "historically high," have fallen below 90 per cent.

The strain it is happening with

• The strain has a name. AusTrakka genomic analysis groups the locally acquired cases in WA, the NT, SA and Queensland as one closely related outbreak group, designated AUS-2026. The analysis finds it distinct from, but likely descended from, the same ancestral lineage as the 2020 to 2023 North Queensland cluster (QLD-2020), and states that genomics alone cannot establish definitive epidemiological links.
• Penicillin resistance, in the official words. WA's clinician alert preferred macrolides "due to increasing penicillin resistance" as early as 12 March; the national guideline, five months later, states a significant proportion of outbreak isolates show reduced penicillin sensitivity and recommends increased doses or alternatives; and the NT's published laboratory finding is the precise version, "susceptible with increased exposure": not resistant, but needing more drug.
• The form it takes.
  • 65.5 per cent of 2026 cases are cutaneous (336)
  • 32.4 per cent respiratory (166)
    • 11 pending.
  • All 166 respiratory cases were locally acquired.
  • WA's early-July split ran higher on the severe side: 66 of 170 cases respiratory, 38.8 per cent, with two severe respiratory cases in the state before the Perth child.
• Who and where. 95.5 per cent of 2026 cases (490 of 513) are among Aboriginal and Torres Strait Islander people, against around 10.5 per cent between 2014 and 2019.
  • Median age is 26 for cutaneous cases and 17 for respiratory.
  • 99 per cent of locally acquired cases live in areas classified outer regional, remote or very remote, 88.4 per cent remote or very remote.
• The NT series, peer-reviewed.
  • The Eurosurveillance paper gives the gradient at case level: median time since last vaccine 9.3 years for the NT's respiratory cases against 4.5 for cutaneous, and of its twelve severe respiratory cases, two were unvaccinated and seven of the remaining ten had gone more than ten years without a dose.
  • Every tested skin lesion was polymicrobial, golden staph and Group A strep alongside the diphtheria organism, and the authors state plainly that the pathogenic role of cutaneous C. diphtheriae amid recent vaccination and those co-infections is uncertain.
• What it rides on. The guideline makes the skin-sore link official: cutaneous diphtheria commonly co-occurs with Group A Streptococcus and Staphylococcus aureus infections, and preventing and treating skin sores reduces infection, carriage and transmission; the prevention list for this bacterial outbreak includes the National Healthy Skin Guideline.
• Four cases that are not part of it. The year's four C. ulcerans cases, zoonotic (raw milk, animal contact), are unrelated; the outbreak is C. diphtheriae throughout.

The May picture

• The situation at 20 May. More than 220 confirmed cases nationally, about thirty times the recent annual average: 133 in the NT, 79 to 82 in WA, six in the APY Lands, five in Queensland. A quarter of all cases had been hospitalised; about a third were the throat form. Cases were falling, from up to 22 new reports a week at peak to nine in the seven days to 26 May.
• The WA outbreak. Identified from late December 2025, mainly affecting Aboriginal people in the Kimberley. The department's first clinician alert, 12 March, counted seven cases, five skin and two respiratory, and told doctors the respiratory pair were the first notified in WA in over 50 years. By late May the count was 73 of WA's 82 cases in the Kimberley, spread to the Goldfields and Pilbara, with one metropolitan case already reported.
• The prison. Two cases were linked to West Kimberley Regional Prison in Derby in late May, at separate times over two months. The Department of Justice's account: neither infection was acquired at the prison, and both people were isolated until they returned negative tests. A Justice communicable disease team travelled the affected regions vaccinating eligible prisoners, with staff able to access state-funded vaccines; Corrective Services sources at the time said staff had been left in the dark about which facility was affected.
• The death. One confirmed: a man from the Big Rivers region who died at Royal Darwin Hospital in April, "probable" once overseas toxicology confirmed the toxin, the first fatal case in Australia since 2018, and the outbreak's argument in one person: all his childhood vaccines, no booster in the past ten years. A second reported death, in Alice Springs, was confirmed not diphtheria-related.

The winter

• June, in the press. 171 WA cases by 28 June, more than 62 per cent of them in the preceding eight weeks; the first Mid West case on 29 June took the outbreak to a majority of WA regions, with the national total at 401 and WA at almost 44 per cent. AMA WA President Kyle Hoath: diphtheria "should not have any sort of a grip on the Western Australian population."
• July, in the series. NT cases averaging sixteen a week, a Tennant Creek patient in intensive care, and a death under coronial investigation; then the CDC's 20 July update, the curve declining, the genomic label published.
• The coronial investigation, now with its details. The NT Coroner is investigating the death of a three-year-old boy overnight on 9 July in Canteen Creek, south-east of Tennant Creek. His family believes diphtheria was the cause; that is the family's belief and the investigation's question, not a finding. If the Coroner confirms the cause, the toll becomes two, and the second is a child.
• What the weekly reports show. The May fall did not continue: WA ran at five to twelve cases a week all winter, peaking in early August, reaching 226 cumulative by the end of week 33, against one case in all of 2025 and zero in 2024. The report's own baseline column cannot express it: with a five-year mean of 0.0, the outbreak ratio reads 0.0.
• Where the cases are. Cumulative rates per 100,000: Kimberley 412.3, more than fifty times the state's 7.5; Pilbara 78.0, Goldfields 8.6, Midwest 4.2; two metropolitan cases, both with onsets before 25 June. The regional sequence matches the southward movement the press describes, and the Mid West leg was in the WA Country Health Service's public messaging on 9 August, eighteen days before the newspaper carried it as news.

Where it stands now

• The count.
  • 460 by the CDC's 20 July update;
  • 513 by 10 August, of which 95 (18.5 per cent) hospitalised;
  • 540 on the national dashboard this week:
    • 290 in the NT,
    • 227 in WA,
    • 18 in SA,
    • five in Queensland.
  • The pace has eased, 26 cases in the latest fortnight against close to 80 at the autumn peak.
• Against the record. Australia's previous annual high was 31 cases, in 2022; since notifications began in 1991, most years recorded between zero and twelve.
  • This year is seventeen times the record. The dashboard's own series shows the break: Queensland's 25 in 2022 was the largest single-jurisdiction year, the NT had nine cases in all of 2025, and WA's counts were suppressed as under five in every recent year before 227.
  • Two caveats: cutaneous cases were undercounted before 2017, when notification was not nationally required; and SA Health's alert carries an unreconciled 65-case national figure.
• Where it is going.
  • Of the 45 cases in the four weeks to 10 August, 23 were in WA against 17 in the NT: the cumulative NT majority conceals a current WA majority.
  • Median age in that window was 13, against 23 for the year, with 24 of the 45 under fifteen; recent hospitalisation 11 per cent against 18.5.
• What a year changed.
  • 2025: 26 cases nationally, median age 36.5, half Indigenous, 92 per cent cutaneous.
  • 2026: twenty times the count, the median age down from 36.5 to 23, and the Indigenous share risen from half to the near-universal figure above.
• The counting caveat. Testing has declined. NACCHO medical adviser Dr Megan Campbell, to the ABC: the true trajectory may not be what the counts show.
• The coverage question. Childhood vaccination hit a five-year low in 2025, and Archana Koirala of the University of Sydney notes hospitalised cases were likely underimmunised; but low coverage did not ignite this. Almost three-quarters of May's confirmed cases had four or more prior doses.
• The world behind it. 85 per cent of infants worldwide received the three-dose series in 2025; no WHO region is free of diphtheria; only 83 countries run all three recommended boosters and 42 run none. The WHO also notes resistance to common antimicrobials in many current strains.

.

[The history - a century on file]

• The disease, before the vaccine. The worst year on record was 1921: 23,199 notifications, 426 per 100,000, 898 deaths. Diphtheria stayed a top-ten cause of child death into the 1930s, killing more than 4,000 Australians between 1926 and 1935.
• What was tried first. Australia's 1916-1922 carrier-control era legislated to treat healthy carriers as cases and swabbed whole towns, 7,000 swabs and 500 isolated carriers in Bendigo alone, and collapsed under its own logistics; the Medical Journal of Australia moved from endorsing the campaigns in 1921 to urging mass immunisation in 1922. The 2026 guideline's triage doctrine codifies, with better tools, the conclusion the system reached a century ago about isolating a carrier-borne disease.
• The vaccine's road. Council campaigns from 1923; the 1928 Bundaberg disaster, twelve children dead within a day from contaminated immunisation material, suspended virtually all diphtheria immunisation for two years; the school-based program from 1932, scaling through the 1940s; the National Immunisation Program from 1975. The between-era baseline this outbreak broke: 42 hospital admissions across 1994 to 2016, three deaths across 1997 to 2016.
• The reservoir, with an address. A 1994 report documented "the frequent isolation of toxigenic and non-toxigenic C. diphtheriae at Alice Springs Hospital"; a 2000 paper listing the world's known reservoirs of toxigenic C. diphtheriae named three: the United States, South East Asia, and central Australia. The CDI's 1999-2019 review states it as standing fact, non-toxigenic diphtheria "remains endemic in Central Australia," and non-toxigenic strains can acquire the toxin gene by bacteriophage; the laboratory record quantifies the quiet, zero toxin-positive isolates among 292 tested across 2005-2011 and 2022, until systematic testing from March 2025 found positivity climbing to an April 2026 peak. Documented thirty-two years before this outbreak, and never gone.
• The paradox, stated in 1997. Adults are susceptible even if previously immunised, for lack of natural boosting, and "this is a direct result of previous success in eradicating the organism from the community." Eradication built the gap.
• The gap, measured. A 1972 Victorian serosurvey found only 40 per cent of adults in their forties immune. A 1998 Sydney study of 548 adults found one quarter with no detectable diphtheria antibodies; national serosurveys in 1997-98 and 2007 confirmed it, with immunity falling to about 60 per cent in adults over 50, "suggesting that almost half of older adults may be susceptible." The 2026 guideline cites the same quarter. Behind it, a cohort: childhood coverage in the 1970s and 1980s ran at an estimated 59 to 75 per cent, and that generation is now in its forties to seventies. In June 2000, analysing the former-Soviet epidemic, the CDI wrote that "existence of a pool of susceptible adults in Australia would be of concern."
• The policy that softened. The adult booster at 50, introduced in 2000, replaced a booster every ten years; the outbreak's five-year interval is stricter than even the pre-2000 rule.
• The 1997 preparedness list. The same editorial's recommendations read as a description of the 2026 response, item for item: improve childhood uptake; maintain surveillance and bacteriological diagnostic skills; better adult immunisation; and "being prepared to embark upon localised mass immunisation of susceptible populations... should an outbreak occur." Everything the response is now doing was on the list twenty-nine years earlier.
• The model that failed. The 2000 paper judged large-scale outbreaks unlikely, because extensive spread requires "a pool of susceptible children, acting as the reservoir for infection," and Australian childhood coverage was high. It still is, 93.4 per cent, and the outbreak happened anyway, concentrated in largely vaccinated children. The assumption was the field's, not just Australia's: the 2020 evidence review states that past research assumed vaccination blocks colonisation, immunity is lifelong, and only the symptomatic transmit, and that this "resulted in flawed estimates of key epidemiologic and disease control measures." The correction reached the literature in 2019, six years before the outbreak that made it observable here.
• The zero that broke. No respiratory diphtheria in an Australian child under 15 from 1999 to 2019; a NSW toddler's intensive-care case was the first since 1992. The 2026 outbreak's recent median age is 13.
• How the last one ended. The former-Soviet epidemic that prompted the 2000 warning was ended the hard way: more than 140 million adults and adolescents vaccinated.

The structural finding. Nothing in this section was secret and none of it was new when the outbreak arrived. The outbreak did not defeat the record. It found the gap between what the record held and what anyone was required to reread.

.

[The government response - money, deployments, and a dispute over speed]

• The declaration and the money. On 22 May the Australian CDC declared the outbreak a Communicable Disease Incident of National Significance. The federal package, $7.2 million at announcement, now totals $13 million, including $3 million for NACCHO to deliver community liaison and on-the-ground health support.
• The NT program. 10,407 vaccinations across the Territory from 30 March to late May, run with Aboriginal Community Controlled Health Organisations, with pop-up clinics in Darwin, Katherine and Alice Springs. (Some May reporting spread "10,000 in seven weeks" across four jurisdictions; it is an NT figure, carried here as the minister's release states it.) At 25 May the program was reaching about 11 per cent of the high-risk population. NT Aboriginal children get an additional booster five years from their last dose, closing the gap between the four-year and twelve-year scheduled doses, with remote-school students and Education staff eligible on the same condition.
• The AUSMAT deployments. Tennant Creek from late June: mobile clinics with Anyinginyi Health Aboriginal Corporation, four-hour sessions at the health centre and three community living areas; the clinics went to the town camps rather than asking the town camps to come to them. The Fitzroy Valley now, with Nindilingarri Cultural Health Services and WA Country Health Service, the first of several planned. Armstrong: the teams work alongside local organisations, "including Aboriginal Community Controlled Health Services, which have been driving vaccination activities and protecting communities throughout the response."
• Who can get a free booster.
  • All Aboriginal people across WA, and non-Aboriginal people in the Kimberley, Pilbara, Goldfields or Midwest; both extensions date from early July, not the Perth case.
  • Everyone else statewide is advised a booster past five years, via GP, community clinic or Aboriginal Medical Service.
  • Reach so far, Armstrong says: "Almost 18,000 people in the outbreak-affected regions have received a diphtheria-containing vaccine over the last three to four months," through outreach, door-to-door visits and pop-up clinics. (July's "almost 15,000" counted doses distributed, not people.)
• The five-year interval, four ways. The outbreak's signature number appears again as OVAHS's offer to anyone in its community without a dose in five years and as the Aboriginal Health Council of WA's extra booster where diphtheria is spreading; with the WA statewide advice and the NT child scheme above, each source attaches the same five years to a different population.
• Victoria, with zero cases. An expanded state-funded Boostrix campaign: free doses for Aboriginal and Torres Strait Islander Victorians over 20, and for anyone moving to live or work in a higher-risk area without a dose in five years. The campaign vaccine carries order limits, a supply-management signal. The response's footprint now exceeds the outbreak's.
• Coverage, and who the numbers miss. National five-year-old coverage is 93.4 per cent, 94.7 among Aboriginal and Torres Strait Islander children, gradually declining since 2020, with the NT lowest at 91.9. Burgess's below-90 stands beside these because his denominator is specific remote communities, and the outbreak runs in the places his number describes. Adult coverage in affected areas is rising.

The dispute over its speed

• The timeline, from the leak. Leaked NT Health data, published in the 30 May post: cases surged in the last week of February; the public alert came 25 March, a month later; the NT did not formally request Commonwealth assistance until late April, two months after the surge. The first cases date to October. The ABC's August report of the leak matches this timeline.
• The critics. James Ward, director of the University of Queensland's Poche Centre for Indigenous Health: "We knew about this in October, November last year. We were calling for action, but the response has been far too slow," and the slowness is systemic: "the response is too slow for syphilis, and the response has been slow for tuberculosis and Shigella." NACCHO's Dawn Casey, in May: "The government has taken a number of weeks to respond but they have responded in a comprehensive way. They just do need to, in future, respond much more quickly than they have."
• The defence. Burgess: the NT enacted proportionate efforts from the first 2025 cases, vaccine promotion, contact advice, community partnership. The leaked timeline sits with the critics; the defence is on the record beside it. Ward, cutting the other way: "It's very easy to blame populations when something like this happens."
• The ground truth. From Yuendumu: no hand sanitiser at the clinic, a three-week test turnaround against four days at Alice Springs hospital, isolation advice with no duration, and service providers not told they were facing an outbreak. Warlpiri man Eugene Penhall: "The thing about this outbreak is that we've never been told what it is."
• The inquiry. Health Minister Mark Butler flagged one. Burgess would "absolutely" welcome it, to understand "how our Australian health protection systems have let us down."
• The housing argument. NACCHO's Dr Megan Campbell: overcrowded housing "not been designed or maintained for large families," "inadequate health hardware in the home"; the prevention list is beds, bedding, towels, consistent water and soap. Epidemiologist Adrian Esterman: "We can vaccinate until the cows come home, but it won't help unless they do something about housing and sanitation." The peer-reviewed NT paper ends on the same ground, "improvements to housing must be prioritised," and the load lands where Campbell says it does: "an incredible strain on Aboriginal community controlled health services."

.

[The instrument the winter produced]

• A new national rulebook. The Communicable Diseases Network Australia issued Version 1 of national diphtheria guidelines for public health units on 21 August, endorsed 28 July. Both forms are classified Urgent, response initiated immediately and data entered within one working day, with respiratory cases taking priority only where resources force a choice. The guideline ships with a national enhanced case-investigation form; that pipeline is how the national dataset knows the outbreak's resistance profile and genomic shape.
• What it authorises when the outbreak outruns the system. Under widespread transmission the guideline permits triage: empiric treatment, laboratories pointed at case detection rather than clearance testing, contact tracing limited to high-risk exposures, and shifting the response toward preventing classic respiratory diphtheria through vaccination "rather than attempting to control transmission and mild disease." Containment officially yields to severity-prevention.
• The numbers under the triage. Vaccination alone interrupts transmission in only 27 per cent of outbreak settings, which is why isolation and antibiotics are essential. Speed is the variable: treating a quarter of symptomatic cases five days after fever onset stops transmission in 35 per cent of settings; half within two days, 48 per cent; ninety per cent within a day, 70 per cent.
• The precedent. Wujal Wujal, East Cape York: contact tracing, community engagement, then a week-long mass vaccination of everyone 14 and over lifted coverage to 88 per cent, and no further cases for 22 months. The playbook has worked in an Australian Aboriginal community before.
• Two things the document admits. Its evidence review was conducted by a single CDC staff member, unrepeated by a second, before working-group review; the instrument says so on its own pages. And the evidence names an isolation gap: clearance averages 5.2 days while international guidance recommended 48 hours of isolation and "may be insufficient"; the Australian clearance-swab regime sits on the stricter side.
• The structural conditions, named officially. Elevated risk in Aboriginal and Torres Strait Islander communities is attributed to structural determinants including the ongoing impacts of colonisation, crowded living and environmental conditions, alongside the operational constraints of remote response: laboratory turnaround, weather access, workforce, surge accommodation, telecommunications, specimen transport.
• Where the chain ends. In Fitzroy Crossing, Nindilingarri Cultural Health Services has a plain-language poster in circulation that renders the clinical content whole: "throat diphtheria" and "skin diphtheria," "special medicine to stop the poison" for the antitoxin, "deep sores that do not heal... often on the legs" as the recognition cue, and the vaccine by its products: "Ask your clinic if your DTP or dTpa needle is up to date."

.

[Watch points]

These are the open questions this thread leaves, including the figures it has not been able to reconcile.

• The Perth case. Whether the source of the infection is identified, and whether any further cases follow from the school contact tracing.
• The coronial investigation. The NT Coroner's finding on the Canteen Creek death. Until it is handed down, the confirmed toll is one.
• Butler's inquiry. Flagged in May, welcomed by the NT Chief Health Officer. Whether it has been established, what its terms are, and whether it examines the fall in remote-community childhood vaccination rates below 90 per cent.
• The case trend. Whether the current decline continues, and whether the testing drop the ABC's experts flag is masking the real number.
• Vaccination reach. May's figure was a proportion (11 per cent of the high-risk population); August's is a count (almost 18,000 people vaccinated). The proportion of the high-risk population now covered remains the open number.
• Penicillin resistance. Whether the resistance profile has changed, and what it means for treatment protocols in remote clinics.
• The unreconciled figures. SA Health's 65-case national figure against the CDC's 230, both May-era for the same calendar year; the basis of the SA figure remains unexplained.

.

AI-assistance disclosure: this post was researched and drafted with the help of an AI assistant (Claude), working from primary sources under my direction. I select and verify the sources, direct the analysis, and edit and check the final text; all errors are mine.